Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
NCT00334906
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
memantine HCl
Sponsor
Forest Laboratories